Painting inside a pharmaceutical manufacturing facility: GMP compliance, coating selection, and documentation

Pharmaceutical manufacturing facilities present a unique set of industrial painting challenges that most general painting contractors — and even many industrial painting contractors — are not equipped to navigate. The intersection of Good Manufacturing Practice (GMP) regulatory requirements, stringent environmental controls, chemical exposure from pharmaceutical production processes and cleaning agents, and the documentation standards of regulated manufacturing creates a coating project environment where the wrong contractor choice carries regulatory and operational consequences that far exceed a simple quality failure.

Why pharmaceutical facilities require specialized coating expertise

In a GMP pharmaceutical manufacturing environment, the facility itself is part of the product's manufacturing system — and it is subject to inspection and qualification accordingly. Coating materials applied to walls, ceilings, and floors in production areas must be compatible with the facility's cleaning and sanitizing agents, must not shed particles that could contaminate product, must be capable of withstanding the cleaning frequencies and chemical concentrations required by the facility's cleaning validation program, and must be documented in a manner that satisfies the facility's quality system and potential regulatory inspection.

A painting contractor who has never worked in a GMP environment may not understand that their choice of coating product, their application method, or even their personal protective equipment requirements must be vetted and approved before work begins. Alpine's extensive experience in pharmaceutical manufacturing environments throughout the NJ and PA pharma corridors means we understand these requirements and operate within them as a matter of standard practice.

Coating system selection for GMP environments

Production areas and cleanroom-adjacent spaces

Walls and ceilings in pharmaceutical production areas require coating systems that are smooth and non-porous — preventing the harboring of microorganisms or particulate in surface irregularities — and chemically resistant to the disinfectants, sanitizers, and cleaning agents specified in the facility's cleaning SOP. Common agents include quaternary ammonium compounds, hydrogen peroxide, sodium hypochlorite, and isopropyl alcohol, and the coating system must be resistant to all agents used at the specified concentrations and contact times.

Two-part epoxy systems are the most common specification for production wall and ceiling coatings, providing the required chemical resistance and a smooth, non-porous surface that cleans effectively and resists microbial harbor. Semi-gloss or gloss finishes are typically specified over flat finishes for ease of cleaning and visual inspection of cleanliness.

Production floors

Pharmaceutical production area floors must withstand the same chemical exposure as walls and ceilings, with the additional demands of foot traffic, wheeled equipment, and frequent wet mopping or washdown. Seamless urethane or epoxy flooring systems with full cove base detailing — eliminating the wall-floor joint where contamination accumulates — are the standard specification for GMP production floors. System selection is driven by the specific chemicals used, cleaning frequency, and whether the area is a wet or dry process environment.

Documentation requirements for GMP painting projects

The documentation requirements for painting in pharmaceutical facilities go well beyond the project records that industrial contractors typically provide. The facility's quality system will typically require the contractor to provide material qualification documentation demonstrating that the proposed coating products are compatible with the facility's cleaning agents, a method statement or work instruction for the painting scope that has been reviewed and approved by the facility's quality team, application records including product lot numbers, ambient conditions at time of application, wet and dry film thickness measurements, and inspector sign-off, and a close-out package that can be filed as part of the facility's qualification documentation.

Alpine provides all of these documentation elements as standard deliverables on pharmaceutical facility projects, and we adapt our documentation formats to align with the facility's quality system requirements. This capability is a direct result of 50 years of working in regulated industrial environments — we know what the documentation needs to say and how to produce it efficiently.

Operational requirements: working in an active GMP facility

Most pharmaceutical painting projects occur in active or recently active manufacturing facilities where product, equipment, and cross-contamination risks must be carefully managed. Alpine develops detailed work plans that define containment measures to prevent coating dust, vapors, and debris from migrating to active production areas, staging and material storage protocols that prevent unauthorized materials from entering controlled areas, gowning and entry procedure requirements for our crews, and scheduling sequences that allow painting to proceed in sections while maintaining continued access to adjacent areas.

This operational discipline is not improvised — it is developed in coordination with the facility's EHS, operations, and quality teams before a single brush is picked up, and it is followed to the letter throughout the project.

Ready to discuss your project?

Alpine Painting & Sandblasting Contractors has served commercial and industrial clients throughout New Jersey, New York, Connecticut, and Pennsylvania for over 50 years. Our SSPC QP1 and QP2-certified teams, AMPP Senior Certified Coating Inspectors, and award-winning safety program are ready to work for your facility.

Contact Besi Janova or David Quiroga, our Commercial Project Estimators, to request a no-obligation estimate. Call (866) 596-0349 or visit alpinepainting.com.